Kevin McRaith, president and CEO of Welldoc, is quoted on what 2024 holds for therapeutic advances in the biopharma industry....
Kevin McRaith, president and CEO of Welldoc, is quoted on key 2023 industry trends, including the rise of GLP-1 medications and advancing AI....
Welldoc® is named one of the Top 100 HealthCare Technology Companies of 2023 by The Healthcare Technology Report...
Welldoc's Chief Analytics Officer, Anand Iyer, is quoted alongside Naoyuki Kanda, business producer at Astellas Pharma, in a feature article by the Japan External Trade Organization (JETRO)....
Welldoc's President and CEO, Kevin McRaith, is quoted in the "Scrip Asks" column, which highlights perspectives from corporate leaders on what 2023 holds therapeutic advances in the biopharma industry....
Welldoc's BlueStar® is named one of the best apps in 2023 for managing diabetes by Verywell Health....
